newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., May 19, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and comm